I’m not so concerned about timelines either. There are plenty of milestones coming up prior to FDA approval that should help increase value.
As a comparison look at EBR ($359m MC) & AVR ($331m MC) both have a significantly higher MC than EMV ($181m MC) yet they are still awaiting FDA approval. (Albeit both Class 3 devices).
I’m not so concerned about timelines either. There are plenty of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.020(1.14%) |
Mkt cap ! $148.7M | |||
| Open | High | Low | Value | Volume |
| $1.75 | $1.78 | $1.74 | $22.49K | 12.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 572 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 740 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |